Growth Metrics

Evolent Health (EVH) Notes Payables (2023 - 2025)

Evolent Health has reported Notes Payables over the past 3 years, most recently at $5.1 million for Q3 2025.

  • Quarterly results put Notes Payables at $5.1 million for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $5.1 million (changed N/A YoY), and the annual figure for FY2024 was $171.5 million, changed.
  • Notes Payables for Q3 2025 was $5.1 million at Evolent Health, down from $172.1 million in the prior quarter.
  • Over the last five years, Notes Payables for EVH hit a ceiling of $172.1 million in Q2 2025 and a floor of $991000.0 in Q3 2023.
  • Median Notes Payables over the past 3 years was $171.5 million (2024), compared with a mean of $104.3 million.